valproic acid has been researched along with risperidone in 165 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (8.48) | 18.2507 |
| 2000's | 74 (44.85) | 29.6817 |
| 2010's | 63 (38.18) | 24.3611 |
| 2020's | 14 (8.48) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Auchus, AP; Freeman, A; Green, RC | 1 |
| Centorrino, F; Froeschl, M; Hegarty, JI; Tohen, M; Zarate, CA; Zarate, SB | 1 |
| Keck, PE; McElroy, SL; Strakowski, SM | 1 |
| Baldassano, CF; Ghaemi, SN; Sachs, GS; Truman, CJ | 1 |
| Baldessarini, RJ; Cherkerzian, T; McDonald, J; Muir-Hutchinson, LA; Nakamura, A; Siegel, AJ; Tohen, M; Zarate, CA | 1 |
| Fisman, S; Steele, M | 1 |
| Freeman, MP; Stoll, AL | 1 |
| Chong, SA; Lee, EL; Liow, PH; Tan, CH | 1 |
| Lauterbach, EC | 1 |
| Baldassano, CF; Ghaemi, SN | 1 |
| Lehrer, DS; Sanders, RD | 1 |
| Cohen, D; Dewan, VK; Grewal, R; Waring, EW | 1 |
| Mahendran, R | 1 |
| Amann, B; Erfurth, A; Grunze, H; Marcuse, A; Normann, C; Walden, J | 1 |
| Avenoso, A; Facciolà, G; Giacobello, T; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E | 1 |
| Finkel, J; Hird, S; Solhkhah, R | 1 |
| Ghaemi, SN; Guille, C; Sachs, GS | 1 |
| Miller, PR | 1 |
| Nemeroff, CB | 1 |
| Ghaemi, SN | 1 |
| van Wattum, PJ | 1 |
| Meyer, JM | 1 |
| Bertoldo, M | 1 |
| Bowden, CL; Ghaemi, SN; Grossman, F; Okamoto, A; Sachs, GS | 1 |
| Bronisch, T; Brunner, J; Wetter, TC | 1 |
| Casey, DE; Daniel, DG; Sommerville, KW; Tracy, KA; Wassef, AA; Wozniak, P | 1 |
| Aamo, T; Spigset, O; Sund, JK | 1 |
| Good, CR; Krecko, VF; Petersen, CA | 1 |
| Augustyns, I; Grossman, F; Ravindran, A; Vieta, E; Yatham, LN | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Hume, JH; Kowatch, RA; Kromelis, M; Sethuraman, G; Weinberg, WA | 1 |
| Binder, C; Connolly, M; Kusumakar, V; Leblanc, J; Riccardelli, R; Yatham, LN | 1 |
| Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J | 1 |
| Isaac, MB; Isaac, MT | 1 |
| Dittmann, S; Grunze, H | 1 |
| Grady, MM; Stahl, SM | 1 |
| Casey, DE; Citrome, L; Daniel, DG; Kochan, LD; Tracy, KA; Wozniak, P | 1 |
| Binder, C; Kusumakar, V; Riccardelli, R; Yatham, LN | 1 |
| Cramer, JA; Sernyak, M | 1 |
| Alexander, J; Lacroix, D; Ravindran, A; Silverstone, P; van Schaick, E; Vermeulen, A | 1 |
| Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Jainer, AK; Sundararajan, V | 1 |
| Andrade, C | 1 |
| Kennedy, SH; Konarski, JZ; Mancini, DA; McCann, S; McIntyre, RS; Srinivasan, J | 1 |
| Carbray, JA; Henry, DB; Janicak, PG; Naylor, MW; Pavuluri, MN; Sampson, G | 1 |
| Bahk, WM; Choi, SK; Chung, SK; Jon, DI; Lee, JS; Pae, CU; Paik, IH; Shin, YC; Woo, JM; Yoon, BH | 1 |
| Albertson, T; Camilleri, C; Offerman, S | 1 |
| Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B | 1 |
| Curtis, V | 1 |
| Winter, AS; Witschy, JK | 1 |
| Cho, SC; Chungh, DS; Kim, BN | 1 |
| Raskind, MA; Rosin, RA | 1 |
| Danielyan, A; Kowatch, RA | 1 |
| Apovian, CM; Ness-Abramof, R | 1 |
| Aryal, S; Harral, EM; Herbener, ES; Hill, SK; Pavuluri, MN; Schenkel, LS; Sweeney, JA | 1 |
| Aulakh, JS; Hawkins, JW; Weith, J; Yohanan, M | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Chinnasamy, D; Rudd, R; Velakoulis, D | 1 |
| Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Coffey, B; Green, WH; Ivanov, I; Klein, M | 1 |
| Burke, RS; Parker, JD; Reeves, RR | 1 |
| Caplan, R; Carlson, T; Reynolds, CA | 1 |
| Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Fong, SY; Lam, MH; Wing, YK | 1 |
| Joo, YH; Kim, B; Kim, SJ; Son, JI | 1 |
| Jebaraj, P; Rajkumar, AP; Tharyan, P | 1 |
| Harral, EM; Herbener, ES; Pavuluri, MN; Schenkel, LS; Sweeney, JA | 1 |
| Binder, CE; Fallu, A; Yatham, LN | 1 |
| Citrome, L; Czobor, P; Nolan, KA; Shope, CB; Volavka, J | 1 |
| Brown, BD; Devine, DP; Muehlmann, AM | 1 |
| Aichhorn, W; Hinterhuber, H; Kemmler, G; Marksteiner, J; Stuppaeck, C; Walch, T; Zernig, G | 1 |
| Preskorn, SH | 1 |
| Barzman, DH; Findling, RL | 1 |
| Dervaux, A; Levasseur, M | 1 |
| Oldham, J | 1 |
| Gonzalez-Heydrich, JM; Korndörfer, SR; MacMillan, CM; Mrakotsky, C; Tilley, CA; Withney, JE | 1 |
| Shen, YC | 1 |
| Bahk, WM; Cho, HS; Chung, SK; Ha, K; Jon, DI; Kim, W; Lee, E; Min, KJ; Seo, JS; Shin, YC; Yoon, BH | 1 |
| Abi-Saab, W; Baker, J; Casey, DE; Daniel, DG; Greco, N; Kane, JM; Redden, L; Saltarelli, M; Tamminga, C; Tran-Johnson, T; Wozniak, P | 1 |
| Hauser, D; Ladds, B; Mejia, C; Thomas, P | 1 |
| Boarati, MA; Castillo, AR; Castillo, JC; Fu-I, L | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Bond, DJ; Kauer-Sant'Anna, M; Lam, RW; Yatham, LN | 1 |
| Grahovac, T; Pavlović, E; Peitl, MV; Peitl, V | 1 |
| Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F | 1 |
| Munhoz, RP; Teive, HA; Werneck, LC | 1 |
| Agam, G; Applebaum, J; Belmaker, RH; Bersudsky, Y; Gaiduk, Y; Mishory, A; Podberezsky, A; Sharony, L | 1 |
| de Leon, J; Diaz, FJ; Spina, E | 1 |
| Celio, CI; Henry, DB; Pavuluri, MN; West, AE | 1 |
| Carbray, JA; Findling, RL; Henry, DB; Janicak, PG; Mohammed, T; Parnes, S; Pavuluri, MN; Sweeney, JA | 1 |
| Carbray, JA; Lu, LH; Passarotti, AM; Pavuluri, MN; Sweeney, JA | 1 |
| Bobo, WV; Bonaccorso, S; Chen, Y; Jayathilake, K; Meltzer, HY | 1 |
| Calabrese, JR; Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C | 1 |
| Ellis, JA; Passarotti, AM; Pavuluri, MN; Stevens, MC; Wegbreit, E | 1 |
| Celio, CI; Henry, D; Pavuluri, MN; Weinstein, SM; West, AE | 1 |
| Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K | 1 |
| Axelson, DA; Birmaher, B; Bolhofner, K; Emslie, G; Geller, B; Joshi, P; Lavori, P; Luby, JL; Nusrat, N; Riddle, MA; Robb, A; Ryan, ND; Tillman, R; Vitiello, B; Wagner, KD; Walkup, JT; Wolf, DV | 1 |
| Dickstein, DP | 1 |
| Fitzgerald, JM; Passarotti, AM; Pavuluri, MN; Sweeney, JA; Wegbreit, E | 1 |
| Akiyama, R; Kohashi, K; Okumura, K; Tsuru, T | 1 |
| Hsu, MC; Kuo, CC; Ouyang, WC; Yeh, IN | 1 |
| Ellis, JA; Fitzgerald, JM; Nandam, A; Passarotti, AM; Pavuluri, MN; Stevens, MC; Wegbreit, E | 1 |
| Bhalerao, S; Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Seyfried, LS | 1 |
| Adragna, MS | 1 |
| Chung, AK | 1 |
| Stringaris, A | 1 |
| Axelson, DA; Birmaher, B; Emslie, G; Joshi, P; Luby, J; Riddle, MA; Robb, A; Ryan, ND; Tillman, R; Vitiello, B; Wagner, KD; Walkup, JT; Yenokyan, G | 1 |
| Bowden, CL; Mintz, J; Singh, V | 1 |
| Blader, JC | 1 |
| Axelson, DA; Birmaher, B; Emslie, G; Joshi, P; Luby, J; Riddle, MA; Robb, A; Ryan, ND; Vitiello, B; Wagner, KD; Walkup, JT | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| Bachmann, CJ; Glaeske, G; Hoffmann, F; Kamp-Becker, I; Manthey, T | 1 |
| Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
| Kostic, J; Markovic, J; Plestic, S | 1 |
| Detwiler, R; Deyo, JC; Dupuis, R; Kozlowski, T; Lee, RM; Moss, MC | 1 |
| Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX | 1 |
| Ambaliya, A; Dosi, R; Joshi, H; Patell, R | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Ahmadi, M; Monajemi, MB; Moosavi, SM | 1 |
| Chan, HY; Lee, KI | 1 |
| Hsia, Y; Wong, IC | 1 |
| Altaye, M; Delgado, S; Kowatch, RA; Lagory, D; Monroe, E; Scheffer, RE | 1 |
| Axelson, DA; Joshi, PT; Luby, JL; Nusrat, N; Reinblatt, SP; Riddle, MA; Salpekar, JA; Sanyal, A; Vitiello, B; Wagner, KD; Walkup, JT; Yenokyan, G | 1 |
| Axelson, DA; Birmaher, B; Joshi, PT; Luby, JL; Miller, L; Riddle, MA; Robb, A; Salpekar, JA; Sanyal, A; Vitiello, B; Wagner, KD; Walkup, JT; Wolf, D; Yenokyan, G | 1 |
| Eap, CB; Gründer, G; Kuzin, M; Paulzen, M | 1 |
| Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B | 1 |
| Erkuran, HÖ; Kutlu, A; Önen, Ö | 1 |
| Unger, M; Xiong, G | 1 |
| Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S | 1 |
| Chatterjee, SS; Das, R; Das, S; Mitra, S | 1 |
| Al Jurdi, RK; Alexopoulos, GS; Banerjee, S; Barrett, M; Beyer, J; Bruce, ML; Chen, P; Evans, J; Gildengers, AG; Greenberg, R; Gyulai, L; Kunik, ME; Marino, P; Mulsant, BH; Reynolds, CF; Sajatovic, M; Schulberg, HC; Young, RC | 1 |
| Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU | 1 |
| Birur, B; Cohen, AW; Nagaraja, S; Thippaiah, SM | 1 |
| Mlynek, K; Romanowicz, M; Sola, C; Thusius, N | 1 |
| Elboga, G; Sayiner, ZA | 1 |
| Bertolin, S; Lam, RW; Qian, H; Valdes, M; Wong, H; Yatham, LN | 1 |
| Chen, K; Dickerson, F; Eissa, A; El Bahaey, W; El Chennawi, F; Elboraei, H; ElSayed, H; Elsheshtawy, E; Elwasify, M; Fathi, W; Gur, R; Ibrahim, A; Ibrahim, I; Mansour, H; Nimgaonkar, V; Shahda, M; Tobar, S; Wood, J; Yassein, A; Yolken, RH | 1 |
| Bailey, BY; Blader, JC; Carlson, GA; Crowell, JA; Daviss, WB; Foley, CA; Kafantaris, V; Margulies, DM; Matthews, TL; Pliszka, SR; Sauder, C; Sinha, C | 1 |
| Chouhan, DK; Gupta, S; Narang, A; Sharma, A; Sinha, S | 1 |
| Cortese, S; Novins, DK | 1 |
| Acıpayam, C; Akgüngör, F; Güneş, H; Kütükçü, M | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| Abdelraouf, SM; Aboul-Fotouh, S; Abuelezz, SA; Bahaa, N; Elnahas, EM; Hassan, GAM; Mohamad, MI; Nabil, MM | 1 |
| Chen, ML; Chen, PA; Chen, YC; Sun, CL; Wang, HY | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J | 1 |
| Bhatia, A; Joshi, R; Kaur, G; Kumar, R; Medhi, B; Mishra, A; Prajapat, M; Sarma, P; Sharma, A; Singla, R | 1 |
| Aghamollaii, V; Ghayyem, H; Hassani, M; Hosseini, H; Mayeli, M; Shafie, M; Shakiba, A | 1 |
| Ashour, RH; Atia, AA; Rahman, KM; Ramadan, NM; Zaki, MM | 1 |
| Dadi, FG; Ijigu, GM; Moges, BT; Semman, MF; Tesfaye, BT | 1 |
| Abdelhakam, DA; Aboul-Ela, YM; Aboul-Fotouh, S; Ebeid, MA; Elnahas, EM; Habib, MZ; Negm, EA; Sadek, DR; Tarek, M | 1 |
20 review(s) available for valproic acid and risperidone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New developments in the pharmacologic treatment of schizoaffective disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Clinical Trials as Topic; Clozapine; Drug Therapy, Combination; Humans; Psychotic Disorders; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Treatment Outcome; Valproic Acid | 1996 |
Mood stabilizer combinations: a review of safety and efficacy.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Calcium Channel Blockers; Clinical Trials as Topic; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Lithium; Risperidone; Valproic Acid | 1998 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Cyclohexanecarboxylic Acids; Drug Utilization; Gabapentin; gamma-Aminobutyric Acid; Humans; Polypharmacy; Risperidone; Schizophrenia; Valproic Acid | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiazepines; Family Planning Services; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Teratogens; Triazines; Valproic Acid; Women's Health | 2005 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Pharmacological treatment of pathologic aggression in children.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Child; Drug Prescriptions; Health Status; Humans; Lithium Carbonate; Methylphenidate; Olanzapine; Risperidone; Time Factors; Valproic Acid; Violence | 2008 |
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Lithium Compounds; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone; Serotonin Syndrome; Valproic Acid; Young Adult | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Oxcarbazepine; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tranquilizing Agents; Valproic Acid | 2018 |
An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature.
Topics: Adult; Female; Humans; Menstruation Disturbances; Psychotic Disorders; Risperidone; Tranquilizing Agents; Valproic Acid; Young Adult | 2018 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
39 trial(s) available for valproic acid and risperidone
| Article | Year |
|---|---|
Risperidone in the treatment of mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium Carbonate; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 1996 |
Tiagabine appears not to be efficacious in the treatment of acute mania.
Topics: Acute Disease; Adult; Anticonvulsants; Bipolar Disorder; Drug Therapy, Combination; Female; GABA Antagonists; Hospitalization; Humans; Lithium; Male; Middle Aged; Nipecotic Acids; Psychiatric Status Rating Scales; Risperidone; Tiagabine; Treatment Outcome; Valproic Acid | 1999 |
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 2002 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2003 |
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Treatment Refusal; Valproic Acid | 2003 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Carbamazepine; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Prospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2003 |
Risperidone in acute and continuation treatment of mania.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium Compounds; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2003 |
Antipsychotic-induced weight gain: bipolar disorder and leptin.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain | 2003 |
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Health Services Research; Humans; Olanzapine; Placebos; Risperidone; Schizophrenia; United States; Valproic Acid | 2004 |
Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Area Under Curve; Bipolar Disorder; Double-Blind Method; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Valproic Acid | 2004 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid | 2004 |
The antidepressant effects of risperidone and olanzapine in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Chemotherapy, Adjuvant; Depression; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2004 |
Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Risperidone; Treatment Outcome; Valproic Acid | 2004 |
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Body Mass Index; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Neuroprotective Agents; Psychiatric Status Rating Scales; Risperidone; Topiramate; Valproic Acid | 2005 |
Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder.
Topics: Acute Disease; Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Dysthymic Disorder; Expressed Emotion; Facial Expression; Female; Humans; Lithium Carbonate; Male; Risperidone; Valproic Acid | 2007 |
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Topics: Administration, Oral; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Lithium Compounds; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2007 |
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.
Topics: Adult; Aggression; Anticonvulsants; Antipsychotic Agents; Diarrhea; Drug Therapy, Combination; Female; Hostility; Humans; Linear Models; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Tablets, Enteric-Coated; Treatment Outcome; Valproic Acid; Vomiting | 2007 |
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Valproic Acid; Young Adult | 2009 |
Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
Topics: Adult; Amides; Animals; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mice; Middle Aged; Placebos; Pregnancy; Psychiatric Status Rating Scales; Risperidone; Teratogens; Treatment Outcome; Valproic Acid | 2010 |
Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Outpatients; Risperidone; Treatment Outcome; Valproic Acid | 2010 |
Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.
Topics: Adolescent; Analysis of Variance; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Brain; Child; Double-Blind Method; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Psychiatric Status Rating Scales; Reaction Time; Risperidone; Valproic Acid | 2011 |
A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; GABA Agents; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Valproic Acid; Young Adult | 2011 |
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.
Topics: Buspirone; China; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Risperidone; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Trazodone; Valproic Acid | 2011 |
Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Brain; Brain Mapping; Child; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neural Pathways; Psychomotor Performance; Risperidone; Valproic Acid; Young Adult | 2012 |
Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.
Topics: Adolescent; Aggression; Antimanic Agents; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Double-Blind Method; Female; Humans; Male; Regression Analysis; Risperidone; Valproic Acid | 2011 |
A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Child; Female; Humans; Lithium Carbonate; Male; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 2012 |
Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.
Topics: Adolescent; Affect; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Mapping; Child; Corpus Striatum; Dominance, Cerebral; Double-Blind Method; Drug Therapy, Combination; Emotions; Facial Expression; Female; Frontal Lobe; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Nerve Net; Pattern Recognition, Visual; Risperidone; Temporal Lobe; Valproic Acid | 2012 |
Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Weight; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitals, Psychiatric; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
Topics: Adolescent; Age Factors; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Effect Modifier, Epidemiologic; Female; Humans; Lithium Carbonate; Male; Obesity; Patient Care Team; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 2012 |
Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Compounds; Lost to Follow-Up; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Secondary Prevention; Time Factors; Triazines; Valproic Acid | 2013 |
Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Male; Risperidone; Treatment Outcome; Valproic Acid | 2014 |
Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Risperidone; Valproic Acid | 2015 |
Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Depression; Female; Humans; Lithium Carbonate; Logistic Models; Male; Patient Compliance; Prospective Studies; Risperidone; Suicide; Treatment Outcome; United States; Valproic Acid | 2015 |
Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Medication Adherence; Risperidone; Treatment Outcome; United States; Valproic Acid | 2015 |
GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
Topics: Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Risperidone; Treatment Outcome; Valproic Acid | 2017 |
Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Risperidone; Secondary Prevention; Treatment Outcome; Valproic Acid; Young Adult | 2019 |
Randomized controlled trial of adjunctive Valproate for cognitive remediation in early course schizophrenia.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Humans; Middle Aged; Risperidone; Schizophrenia; Toxoplasmosis; Treatment Outcome; Valproic Acid; Young Adult | 2019 |
Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.
Topics: Aggression; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2021 |
106 other study(ies) available for valproic acid and risperidone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Agitated behavior relieved following treatment of cervical dystonia in dementia.
Topics: Alzheimer Disease; Botulinum Toxins; Chlorpromazine; Dystonia; Female; Humans; Isoxazoles; Middle Aged; Neck Muscles; Phenytoin; Piperidines; Risperidone; Valproic Acid | 1995 |
Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 1997 |
Risperidone in the elderly: a pharmacoepidemiologic study.
Topics: Age Factors; Aged; Aged, 80 and over; Basal Ganglia Diseases; Cardiovascular Diseases; Comorbidity; Delirium; Drug Administration Schedule; Drug Therapy, Combination; Heart Arrest; Hospitalization; Humans; Hypotension; Mental Disorders; Pharmacoepidemiology; Psychotropic Drugs; Risperidone; Sex Factors; Treatment Outcome; Valproic Acid | 1997 |
Bipolar disorder in children and adolescents: current challenges.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Clomipramine; Diagnosis, Differential; Female; Humans; Lithium Carbonate; Male; Patient Care Team; Risperidone; Valproic Acid | 1997 |
Augmentation of risperidone with valproic acid.
Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 1998 |
Catatonia-like events after valproic acid with risperidone and sertraline.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Catatonia; Drug Interactions; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Psychotic Disorders; Risperidone; Sertraline; Valproic Acid | 1998 |
Generalized edema with risperidone: divalproex sodium treatment.
Topics: Adult; Bipolar Disorder; Comorbidity; Edema; Epilepsy, Temporal Lobe; Humans; Male; Risperidone; Valproic Acid | 1996 |
Edema associated with addition of risperidone to valproate treatment.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Female; Humans; Risperidone; Schizophrenia; Valproic Acid | 1998 |
Risperidone as an adjunct to valproic acid.
Topics: Antimanic Agents; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Psychotic Disorders; Risperidone; Treatment Outcome; Valproic Acid | 1999 |
Obsessive-compulsive symptoms with risperidone.
Topics: Antipsychotic Agents; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Risk Factors; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 1999 |
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Risperidone; Valproic Acid | 2000 |
Possible risperidone-induced visual hallucinations.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Hallucinations; Humans; Olanzapine; Pirenzepine; Risperidone; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2000 |
Clozapine therapy for a patient with a history of Hodgkin's disease.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Remission Induction; Risperidone; Treatment Outcome; Valproic Acid | 2001 |
Valproic acid and risperidone.
Topics: Aggression; Antipsychotic Agents; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Male; Risperidone; Treatment Outcome; Valproic Acid | 2001 |
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Glucose Tolerance Test; Hospitalization; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lithium; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Valproic Acid | 2002 |
Valproic acid and risperidone.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Drug Interactions; Epilepsy; Female; Humans; Psychotic Disorders; Risperidone; Tremor; Valproic Acid | 2002 |
Restless legs syndrome probably induced by risperidone treatment.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Polysomnography; Quetiapine Fumarate; Restless Legs Syndrome; Risperidone; Sleep; Valproic Acid | 2002 |
Valproic acid and risperidone: a drug interaction?
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Prospective Studies; Risperidone; Valproic Acid | 2003 |
Valproic Acid and risperidone.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Child; Drug Interactions; Humans; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Valproic Acid | 2003 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Valproic Acid | 2003 |
Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Valproic Acid | 2004 |
Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
Topics: Adolescent; Adult; Age Factors; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survival Analysis; Time Factors; Treatment Outcome; Valproic Acid | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Ethics, Research; Haloperidol; Humans; Lithium; Patient Selection; Placebos; Randomized Controlled Trials as Topic; Research Design; Risperidone; Valproic Acid | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Humans; Randomized Controlled Trials as Topic; Research Design; Risperidone; Treatment Outcome; Valproic Acid | 2004 |
Fatal cerebral edema after moderate valproic acid overdose.
Topics: Adult; Ammonia; Brain Edema; Cyclohexanols; Drug Overdose; Fatal Outcome; Humans; Male; Risperidone; Valproic Acid; Venlafaxine Hydrochloride | 2005 |
Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Risperidone; Severity of Illness Index; Valproic Acid | 2005 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid | 2005 |
Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Temperature; Child; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Impulsive Behavior; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid; Violence | 2005 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Drug-induced weight gain.
Topics: Anticonvulsants; Antipsychotic Agents; Humans; Obesity; Psychotropic Drugs; Risperidone; Valproic Acid; Weight Gain; Weight Loss | 2005 |
Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Cognition Disorders; Comorbidity; Female; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychology, Child; Psychomotor Performance; Risperidone; Valproic Acid | 2006 |
Pisa syndrome in a patient in a wheelchair taking valproic acid.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dystonia; Humans; Male; Psychotic Disorders; Risperidone; Valproic Acid; Wheelchairs | 2006 |
A case of schizophrenia with complete agenesis of the corpus callosum.
Topics: Adult; Agenesis of Corpus Callosum; Antidepressive Agents; Antipsychotic Agents; Cognition Disorders; Female; Humans; Neuropsychological Tests; Psychology; Psychotherapy; Risperidone; Schizophrenia; Valproic Acid | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
The challenges of psychopharmacological management of children with severe developmental disabilities.
Topics: Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Caregivers; Child; Developmental Disabilities; Epilepsy; Female; Foster Home Care; Fructose; Humans; Impulsive Behavior; Mental Status Schedule; Psychological Tests; Risperidone; Status Epilepticus; Topiramate; Valproic Acid | 2006 |
Characteristics of psychotic patients with foreign accent syndrome.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Humans; Language; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Valproic Acid; Verbal Behavior | 2007 |
Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.
Topics: Antipsychotic Agents; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Hyperammonemia; Male; Risperidone; Valproic Acid | 2007 |
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Interactions; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2007 |
Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clonazepam; Dibenzothiazepines; Female; GABA Modulators; Gonadal Steroid Hormones; Humans; Masturbation; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Sexual Dysfunctions, Psychological; Valproic Acid | 2007 |
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Male; Obesity; Olanzapine; Risperidone; Smoking; Valproic Acid | 2008 |
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Overdose; Drug Prescriptions; Female; Humans; Piperazines; Polypharmacy; Risperidone; Schizophrenia, Paranoid; Thiazoles; Trihexyphenidyl; Valproic Acid | 2007 |
Pemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Fructose; Grooming; Male; Motor Activity; Pemoline; Rats; Rats, Long-Evans; Risperidone; Self-Injurious Behavior; Topiramate; Treatment Outcome; Valproic Acid | 2008 |
Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
Topics: Adolescent; Adult; Aging; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone; Sex Characteristics; Smoking; Tandem Mass Spectrometry; Valproic Acid | 2007 |
Deconstructing a medication regimen.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid | 2008 |
Risperidone and valproate for mania following stroke.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Middle Aged; Risperidone; Stroke; Valproic Acid | 2008 |
Indications.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Child; Drug Approval; Evidence-Based Medicine; Humans; Patient Selection; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration; Valproic Acid | 2008 |
Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Body Weight; Child; Child, Preschool; Comorbidity; Female; Humans; Male; Personality Assessment; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2008 |
Unilateral rubral tremor following treatment with risperidone.
Topics: Anticonvulsants; Antipsychotic Agents; Ataxia; Behavior Therapy; Bipolar Disorder; Brain; Carbamazepine; Clonazepam; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Neural Pathways; Neurologic Examination; Red Nucleus; Risperidone; Valproic Acid; Young Adult | 2009 |
Revised Korean medication algorithm for bipolar disorder.
Topics: Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Health Personnel; Humans; Korea; Olanzapine; Psychiatry; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Valproic Acid | 2009 |
Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Risperidone; Schizophrenia; Valproic Acid | 2009 |
[Gilles de la Tourette syndrome in a child with bipolar disorder].
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Male; Risperidone; Tourette Syndrome; Valproic Acid | 2008 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Insulin; Lithium Carbonate; Male; Obesity; Olanzapine; Overweight; Prospective Studies; Quetiapine Fumarate; Risperidone; Triglycerides; Valproic Acid; Weight Gain; Young Adult | 2010 |
Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Galactorrhea; Humans; Middle Aged; Risperidone; Valproic Acid | 2010 |
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Ethnicity; Female; Humans; Lithium Carbonate; Male; Observation; Olanzapine; Personality Disorders; Prospective Studies; Quetiapine Fumarate; Remission Induction; Risperidone; Severity of Illness Index; Substance-Related Disorders; Valproic Acid | 2010 |
The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Topics: Aged; Antipsychotic Agents; Cinnarizine; Cohort Studies; Diagnosis, Differential; Female; Flunarizine; Haloperidol; Humans; Male; Methotrimeprazine; Movement Disorders; Outpatient Clinics, Hospital; Parkinsonian Disorders; Psychotic Disorders; Risperidone; Severity of Illness Index; Time Factors; Valproic Acid | 2010 |
Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Metabolic Clearance Rate; Olanzapine; Risperidone; Valproic Acid | 2010 |
Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Child; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Male; Parents; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Risperidone; Sampling Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome; Valproic Acid | 2011 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid | 2012 |
This is your brain. This is your brain on treatment. Any questions?
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Corpus Striatum; Female; Frontal Lobe; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Net; Risperidone; Temporal Lobe; Valproic Acid | 2012 |
[Case of a 13-year-old boy with hyponatremia due to lamotrigine-induced syndrome of inappropriate secretion of antidiuretic hormone].
Topics: Adolescent; Anticonvulsants; Drug Therapy, Combination; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lamotrigine; Male; Risperidone; Triazines; Valproic Acid | 2012 |
Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder.
Topics: Adolescent; Age Factors; Amygdala; Bipolar Disorder; Child; Female; Humans; Lamotrigine; Male; Nerve Net; Predictive Value of Tests; Psychomotor Performance; Risperidone; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Valproic Acid | 2012 |
A functional magnetic resonance imaging study of risperidone and divalproex.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Corpus Striatum; Female; Frontal Lobe; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Net; Risperidone; Temporal Lobe; Valproic Acid | 2012 |
Atypical presentation of tardive dyskinesia associated with risperidone long-acting injection as maintenance treatment in bipolar affective disorder: a case report.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Injections; Lithium Compounds; Male; Middle Aged; Neck; Risperidone; Valproic Acid | 2012 |
What we can all learn from the Treatment of Early Age Mania (TEAM) trial.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium Carbonate; Male; Patient Care Team; Risperidone; Valproic Acid | 2012 |
Another look at the Treatment of Early-Age Mania (TEAM) trial.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium Carbonate; Male; Patient Care Team; Risperidone; Valproic Acid | 2013 |
Dr. Vitiello et al. reply.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium Carbonate; Male; Patient Care Team; Risperidone; Valproic Acid | 2013 |
Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Germany; Humans; Infant; Infant, Newborn; Male; Methylphenidate; Prevalence; Risperidone; United States; Valproic Acid; Young Adult | 2013 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Concordant response to pharmacotherapy in monozygotic twins with schizoaffective disorder.
Topics: Affect; Alopecia; Antipsychotic Agents; Diseases in Twins; Drug Therapy, Combination; Emotions; Humans; Male; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychotic Disorders; Remission Induction; Risperidone; Treatment Outcome; Twins, Monozygotic; Valproic Acid; Young Adult | 2013 |
Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible?
Topics: Biopsy; Bipolar Disorder; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Kidney Transplantation; Lithium; Middle Aged; Nephritis, Interstitial; Renal Insufficiency; Risk; Risperidone; Tacrolimus; Treatment Outcome; Valproic Acid | 2014 |
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult | 2014 |
Alcohol withdrawal delirium manifested by manic symptoms in an elderly patient.
Topics: Alcohol Withdrawal Delirium; Alcoholic Intoxication; Bipolar Disorder; Drug Therapy, Combination; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Postoperative Complications; Risperidone; Taiwan; Valproic Acid | 2015 |
Authors' response to Bachmann and Hoffman's comments on psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.
Topics: Child Development Disorders, Pervasive; Female; Humans; Male; Methylphenidate; Risperidone; Valproic Acid | 2015 |
Pharmacokinetic Interaction Between Valproic Acid, Meropenem, and Risperidone.
Topics: Adult; Anti-Bacterial Agents; Drug Interactions; Humans; Male; Meropenem; Risperidone; Thienamycins; Valproic Acid | 2016 |
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paliperidone Palmitate; Risperidone; Triazines; Valproic Acid; Young Adult | 2016 |
Treating an Adolescent with Long QT Syndrome for Bipolar Disorder: A Case Presentation.
Topics: Adolescent; Bipolar Disorder; Female; Humans; Long QT Syndrome; Lorazepam; Risperidone; Valproic Acid | 2017 |
Treatment of refractory psychogenic polydipsia with lithium.
Topics: Antipsychotic Agents; Enzyme Inhibitors; Humans; Hyponatremia; Lithium; Male; Polydipsia, Psychogenic; Risperidone; Seizures; Valproic Acid; Water Intoxication | 2017 |
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Haloperidol; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Risperidone; Social Behavior; Valproic Acid | 2017 |
The damaged cortices and the uncontrolled Id: A case of post-measles hyper-sexuality.
Topics: Antipsychotic Agents; Brain; Brain Diseases; Child; Diagnosis, Differential; GABA Agents; Humans; Id; Male; Measles; Positron-Emission Tomography; Risperidone; Sexual Behavior; Valproic Acid | 2017 |
Prolonged Psychosis Associated with Left Insular Stroke: Talking to God in the Walls.
Topics: Aged; Antimanic Agents; Antipsychotic Agents; Cerebral Cortex; Electroencephalography; Hallucinations; Humans; Male; Psychotic Disorders; Risperidone; Stroke; Time; Valproic Acid | 2018 |
Rare cause of manic period trigger in bipolar mood disorder: testosterone replacement.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Chorionic Gonadotropin; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Risperidone; Testosterone; Valproic Acid | 2018 |
Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Epilepsy, Absence; Female; Gait; Gait Disorders, Neurologic; Humans; India; Mood Disorders; Muscular Diseases; Risperidone; Trihexyphenidyl; Valproic Acid; Vitamin D Deficiency | 2020 |
Editorial: Why JAACAP Published an "Inconclusive" Trial: Optimize, Optimize, Optimize Psychostimulant Treatment.
Topics: Aggression; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Double-Blind Method; Humans; Retrospective Studies; Risperidone; Valproic Acid | 2021 |
Leukemia-like megaloblastic anemia in an autistic child receiving risperidone and valproic acid.
Topics: Anemia, Megaloblastic; Autistic Disorder; Child; Humans; Leukemia; Risperidone; Valproic Acid; Vitamin B 12 Deficiency | 2020 |
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Female; Male; Metformin; Peroxisome Proliferator-Activated Receptors; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Risperidone; Tauopathies; Valproic Acid | 2022 |
Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice.
Topics: Animals; Dizocilpine Maleate; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Risperidone; Valproic Acid | 2022 |
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid | 2022 |
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spectrum Disorder; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Granulocyte Colony-Stimulating Factor; Hippocampus; Humans; N-Methylaspartate; Neuroprotective Agents; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, AMPA; Receptors, Glutamate; Risperidone; Saline Solution; Valproic Acid | 2022 |
Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risperidone; Valproic Acid | 2023 |
The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Autophagy; Disease Models, Animal; Female; Humans; Male; Prenatal Exposure Delayed Effects; Rats; Risperidone; Valproic Acid | 2023 |
Management practice and discharge outcome of patients with psychiatric disorder admitted to psychiatry wards of selected specialized settings in Ethiopia.
Topics: Adult; Cross-Sectional Studies; Diazepam; Ethiopia; Hospitals, Psychiatric; Humans; Mental Disorders; Patient Discharge; Psychiatry; Risperidone; Valproic Acid | 2023 |
Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Topics: Adenosine Deaminase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spectrum Disorder; Autistic Disorder; Disease Models, Animal; Female; Glutamic Acid; Pregnancy; Rats; Receptors, AMPA; Risperidone; RNA; RNA Editing; Valproic Acid | 2023 |